Cargando…
Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a newly emerging viral disease with fatal outcomes. However, no MERS-CoV-specific treatment is commercially available. Given the absence of previous structure-based drug discovery studies targeting MERS-CoV fusion proteins, this set of compo...
Autores principales: | Kandeel, Mahmoud, Yamamoto, Mizuki, Al-Taher, Abdulla, Watanabe, Aya, Oh-hashi, Kentaro, Park, Byoung Kwon, Kwon, Hyung-Joo, Inoue, Jun-ichiro, Al-Nazawi, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327142/ https://www.ncbi.nlm.nih.gov/pubmed/32126736 http://dx.doi.org/10.4062/biomolther.2019.202 |
Ejemplares similares
-
Molecular dynamics of Middle East Respiratory Syndrome Coronavirus (MERS CoV) fusion heptad repeat trimers
por: Kandeel, Mahmoud, et al.
Publicado: (2018) -
Discovery of New Potent anti-MERS CoV Fusion Inhibitors
por: Kandeel, Mahmoud, et al.
Publicado: (2021) -
SARS-CoV heptad repeat 2 is a trimer of parallel helices
por: Celigoy, Jessica, et al.
Publicado: (2011) -
The structural basis of unique substrate recognition by Plasmodium thymidylate kinase: Molecular dynamics simulation and inhibitory studies
por: Kandeel, Mahmoud, et al.
Publicado: (2019) -
An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications
por: Lai, Wenqing, et al.
Publicado: (2016)